Patents Assigned to Activesite Pharmaceticals, Inc.
  • Inhibitors of plasma kallikrein
    Patent number: 7977380
    Abstract: The present invention provides compounds that inhibit the activity of plasma kallikrein (PK) and methods of preventing and treating the formation of thrombin during or after a PK dependent disease or condition, for example, after fibrinolysis treatment.
    Type: Grant
    Filed: November 20, 2009
    Date of Patent: July 12, 2011
    Assignee: Activesite Pharmaceticals, Inc.
    Inventors: Sukanto Sinha, Tamie Jo Chilcote